middle.news
Neurizon Taps Global Pharma Leader Before ALS Trial Results
9:02am on Monday 7th of September, 2026 AEST
•
Biotechnology
Read Story
Neurizon Taps Global Pharma Leader Before ALS Trial Results
9:02am on Monday 7th of September, 2026 AEST
Key Points
Dr Chris Bremer to become CEO on 1 October 2026
NUZ-001 trial results expected in late Q2 2027
More than 20 years of pharmaceutical and biotechnology leadership
Over US$1 billion in licensing transactions executed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE